Ultram is a brand name for the generic medication tramadol, which belongs to the opioid analgesic class of drugs. It is primarily prescribed to manage moderate to moderately severe pain in adults.

The mechanism of action of Ultram involves binding to opioid receptors in the central nervous system, thereby modulating the perception of pain. Additionally, tramadol inhibits the reuptake of certain neurotransmitters such as serotonin and norepinephrine, which may contribute to its analgesic effects.

Ultram is available in various formulations, including immediate-release tablets, extended-release tablets, and orally disintegrating tablets. The dosage and frequency of administration are typically determined by a healthcare professional based on the severity of the pain and individual response to the medication.